Last updated on May 2018

Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy


Brief description of study

This randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

Detailed Study Description

Taste disorders are frequent side effects in patients undergoing chemotherapy (CTX). Dysguesia has prevalence rates of 16% to 1000% during CTX with sometimes also persistent courses. Impact of dysguesia on appetite, body weight as well as health-related quality of life was shown. Until now, evidence for adequate treatment options is limited to specific diary recommendations. Acupuncture in the treatment of side effects of chemotherapy was investigated for nausea and xerostomia, but not for dysguesia. Therefore, this randomized controlled trial aims to investigate hypoglossal acupuncture in comparison to sham acupuncture and standard medical treatment (dietary recommendations) in the treatment of dysgeusia in cancer patients undergoing chemotherapy.

Clinical Study Identifier: NCT02304913

Contact Investigators or Research Sites near you

Start Over

Heidemarie Haller, MSc

Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte
Essen, Germany
  Connect »

Aleksandra Schönthal

Department of Senology, St. Josef's Hospital Hilden
Hilden, Germany
  Connect »